Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000034

CEO gave up 358,510 shares (to pay taxes)

  • CEO acquired 97,319 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gline Matthew · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-30 Exercise or conversion : show line 1 in the form +97,319 17,384,400 D
2026-03-30 Shares withheld for taxes : show line 2 in the form −53,826 $26.41 $1,421,545 17,330,574 D
2026-03-31 Shares withheld for taxes : show line 3 in the form −304,684 $27.70 $8,439,747 17,025,890 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-30 Exercise or conversion : show line 4 in the form Capped Value Appreciation Rights −2,178,150 $11.50 $25,048,725 0 D
Loading xslF345X06/wk-form4_1775085629.xml…